These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32432774)

  • 21. Sevoflurane inhibits the progression of PTC by downregulating miR-155.
    Li Y; Zeng QG; Qiu JL; Pang T; Wang H; Zhang XX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6579-6587. PubMed ID: 31378899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
    Qin A; Liu Q; Wang J
    Drug Dev Res; 2020 Sep; 81(6):700-707. PubMed ID: 32314406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).
    Jiao X; Ye J; Wang X; Yin X; Zhang G; Cheng X
    Med Sci Monit; 2019 Sep; 25():6788-6796. PubMed ID: 31501407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-219 inhibits cell viability and metastasis in papillary thyroid carcinoma by targeting EYA2.
    Liu HM; Dong AB; Hua H; Sun YH; Wang JR; Yu QQ; Zhang JH; Sun WH
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9556-9564. PubMed ID: 33015798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-1258: a novel microRNA that controls TMPRSS4 expression is associated with malignant progression of papillary thyroid carcinoma.
    Wang LJ; Cai HQ
    Endokrynol Pol; 2020; 71(2):146-152. PubMed ID: 32154571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1.
    Jiang C; Xu F; Yi D; Jiang B; Wang R; Wu L; Ding H; Qin J; Lee Y; Sang J; Shi X; Su L
    J Endocrinol Invest; 2024 Jan; 47(1):149-166. PubMed ID: 37477865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
    BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
    Gao P; Jiao H; Zhe L; Cui J
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propofol Inhibits Lung Cancer A549 Cell Growth and Epithelial-Mesenchymal Transition Process by Upregulation of MicroRNA-1284.
    Liu WZ; Liu N
    Oncol Res; 2018 Dec; 27(1):1-8. PubMed ID: 29402342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma.
    Ren L; Xu Y; Qin G; Liu C; Yan Y; Zhang H
    IUBMB Life; 2019 Jan; 71(1):28-40. PubMed ID: 30325582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer.
    Sun CX; Liu BJ; Su Y; Shi GW; Wang Y; Chi JF
    Clin Transl Oncol; 2022 Jan; 24(1):66-75. PubMed ID: 34312797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
    Ma S; Jia W; Ni S
    Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/β-catenin signalling activation.
    Gong T; Ning X; Deng Z; Liu M; Zhou B; Chen X; Huang S; Xu Y; Chen Z; Luo R
    J Cell Biochem; 2019 Oct; 120(10):16934-16945. PubMed ID: 31104336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.